DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 1Olpha
03 6Granules India Limited
04 1Accord healthcare
05 2Adamed Pharma
06 1Alhavi Pharma
07 2Alkem Laboratories
08 1Alter Laboratories Sa
09 2Annora Pharma
10 1Aurobindo Pharma Limited
11 1Bausch Health
12 59Boehringer Ingelheim GmbH
13 3CLONMEL HLTHCARE
14 1Demo S.A.
15 3Grupo Azevedos
16 4Intas Pharmaceuticals
17 1Intas Third Party Sales 2005 Sl
18 1InvaGen Pharmaceuticals Inc
19 2Kinapse
20 3Laboratorios Lafage
21 2MEDOCHEMIE LTD
22 6MSN Laboratories
23 1Mahban Group
24 4PharOS Ltd
25 5PharmaPath S.A.
26 4Pharmaline
27 1Pharmapath Sa
28 3Pluviaendo
29 3Prinston
30 5STADA Arzneimittel
31 8Sandoz B2B
32 3Sun Pharmaceutical Industries Limited
33 4Sunshine Lake Pharma
34 2Tecnimede
35 3Varian Pharmed
36 7Viatris
37 5Zentiva
38 4Zydus Pharmaceuticals
01 6Antic-calc Tablet, Film Coated
02 3Each Coated Tablet
03 67Film Coated Tablet
04 4Film Coated Tablet
05 6Immediate Release Tablet
06 1Linagliptin 5Mg 28 Combined Oral Use
07 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
08 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
09 4Oral Solid Dosage Form
10 4TABLET
11 6TABLET, EXTENDED RELEASE;ORAL
12 4TABLET; ORAL
13 38TABLET;ORAL
14 19Tablet
15 2Tablets
16 1Tablets
17 2tablet
18 4Blank
01 5Allowed
02 10Approved
03 18Authorised
04 25Authorized
05 1Dossier Readiness: Q1 2025
06 2Generic
07 4Lead Market Dossiers- Filed
08 4Prescription
09 31RX
10 1Withdrawn
11 72Blank
01 1Diagliptin Deo
02 1Drojarto
03 3EMPAGLIFLOZIN AND LINAGLIPTIN
04 6EMPAGLIFLOZIN; LINAGLIPTIN
05 2Empagliflozin ; Linagliptin
06 1Empiria Complex
07 1Empiria Complex
08 2GLYXAMBI
09 2Girl Duet
10 2Glymetia
11 6Glyxambi
12 1Glyxambi
13 2Ilinpru
14 6JENTADUETO
15 2JENTADUETO XR
16 17Jentadueto
17 3Jentadueto mg
18 7LINAGLIPTIN
19 1LINAGLIPTIN 5
20 17LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
21 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
22 1Liglinra
23 1Linagliptin
24 3Linagliptin ; Metformin Hydrochloride
25 1Linagliptin Accord
26 1Linagliptin Intas
27 1Linagliptin Medochemie5
28 1Linagliptin Pharos
29 3Linagliptin Sandoz
30 1Linagliptin Stada
31 1Linagliptin Viatris
32 1Linagliptin Zentiva
33 3Linagliptin/Metformin Clonmel
34 3Linagliptin/Metformin Hcl Pharos
35 3Linagliptin/Metformin Sandoz
36 1Linagliptina Alter
37 1Linagliptina Medochemie
38 1Linagliptina Pharmapath
39 1Linagliptina Stada
40 2Linagliptina/Metformina Sandoz
41 2Linagliptine/Metformin Stada
42 1Linathan
43 2Meglithan
44 1Melijent
45 1TRADJENTA
46 1TRAJENTA
47 4TRIJARDY XR
48 8Trajenta
49 6Trajentamet
50 1Zyfoqam
51 30Blank
01 12Australia
02 4Canada
03 4Czech Republic
04 3Guatemala
05 14India
06 5Iran
07 3Italy
08 1Latvia
09 4Lebanon
10 19Malta
11 6Norway
12 2Poland
13 5Portugal
14 25Spain
15 10Sweden
16 5Switzerland
17 3Turkey
18 48USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208428
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
